A 6-year prospective, observational, multi-center post-marketing surveillance of the safety of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) …
HJ Park, SJ Kim, J Chen, JH Kim… - Journal of Korean …, 2019 - synapse.koreamed.org
Background Incidence of whooping cough is increasing in Korea. Since 2011, occurrence
among adolescents and adults has risen putting vulnerable neonates at risk. National …
among adolescents and adults has risen putting vulnerable neonates at risk. National …
Safety of diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine in adults in Japan
M Ujiie, S Tsuzuki, M Suzuki, M Ota… - Japanese Journal of …, 2021 - jstage.jst.go.jp
抄録 Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine is
generally used for booster vaccination of infants in Europe and the United States to avoid …
generally used for booster vaccination of infants in Europe and the United States to avoid …
Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents
ML Jackson, O Yu, JC Nelson… - … and drug safety, 2018 - Wiley Online Library
In light of waning immunity to pertussis following receipt of tetanus toxoid, reduced
diphtheria toxoid and acellular pertussis (Tdap) vaccine, maintaining protection may require …
diphtheria toxoid and acellular pertussis (Tdap) vaccine, maintaining protection may require …
[HTML][HTML] Recommendation for the use of newly introduced Tdap vaccine in Korea
KM Choi, KH Kim, YJ Kim, JH Kim, SE Park… - Korean journal of …, 2011 - ncbi.nlm.nih.gov
Pertussis is an acute respiratory infection characterized by paroxysmal cough and
inspiratory whoop for over 2 weeks. The incidence of pertussis has decreased markedly …
inspiratory whoop for over 2 weeks. The incidence of pertussis has decreased markedly …
[PDF][PDF] Preventing tetanus, diphtheria, and pertussis among adults; use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: recommendations …
K Kretsinger, KR Broder, MM Cortese, P Joyce… - 2006 - cdc.gov
Summary On June 10, 2005, a tetanus toxoid, reduced diphtheria toxoid and acellular
pertussis vaccine (Tdap) formulated for use in adults and adolescents was licensed in the …
pertussis vaccine (Tdap) formulated for use in adults and adolescents was licensed in the …
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who …
Centers for Disease Control and … - MMWR: Morbidity & …, 2011 - search.ebscohost.com
Compared with older children and adults, infants aged < 12 months have substantially
higher rates of pertussis and the largest burden of pertussis-related deaths. Since 2004, a …
higher rates of pertussis and the largest burden of pertussis-related deaths. Since 2004, a …
Post-marketing safety evaluation of a tetanus toxoid, reduced diphtheria toxoid and 3-component acellular pertussis vaccine administered to a cohort of adolescents in …
NP Klein, J Hansen, E Lewis, L Lyon… - The Pediatric …, 2010 - journals.lww.com
Background: Prelicensure clinical studies may not include sufficient numbers of subjects to
assess the potential for rare postvaccination adverse events. The aim of this postlicensure …
assess the potential for rare postvaccination adverse events. The aim of this postlicensure …
Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4–65 years of age: A …
I Aydin, M May, F Pisano, N Mpofu-Maetzig, L Grode… - Vaccine, 2023 - Elsevier
Background This study assessed the safety and immunogenicity of a new booster vaccine
against tetanus, diphtheria, and pertussis manufactured by Serum Institute of India Pvt. Ltd …
against tetanus, diphtheria, and pertussis manufactured by Serum Institute of India Pvt. Ltd …
[HTML][HTML] Use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines: updated recommendations of the Advisory Committee on Immunization …
FP Havers - MMWR. Morbidity and mortality weekly report, 2020 - cdc.gov
Background Two Tdap vaccines are licensed for use in the United States. Boostrix
(GlaxoSmithKline) is approved for a single dose in persons aged≥ 10 years; Adacel (Sanofi …
(GlaxoSmithKline) is approved for a single dose in persons aged≥ 10 years; Adacel (Sanofi …
[HTML][HTML] Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women—Advisory …
M Sawyer, JL Liang, N Messonnier… - Morbidity and Mortality …, 2013 - ncbi.nlm.nih.gov
Methods In monthly teleconferences during 2012, the ACIP Pertussis Vaccines Work Group
considered published, peer-reviewed literature and unpublished data relevant to …
considered published, peer-reviewed literature and unpublished data relevant to …